Liver Cancer
📧 Sign up to get email alerts when something new happens for Liver Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation [NA]
A completed feasibility study on 3D perfusion ultrasound for planning and evaluating response to SBRT in liver cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC [Phase 1, Phase 2]
Phase Ib/II trial investigating INC280 plus PDR001 or PDR001 alone in advanced hepatocellular carcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures [Phase 4]
Phase 4 clinical trial updating comparison of hepatic hilar nerve block versus sham for pain control during liver ablation and transarterial…
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer [NA]
Clinical trial update for M5A, a Copper-64 labeled anti-CEA monoclonal antibody used in PET imaging to diagnose CEA-positive cancers; the st…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]
Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial [Phase 3]
A Phase 3 randomized controlled trial evaluating the applicability of 3D-HDRA in patients with primary liver cancer that is resectable.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers [Phase 1, Phase 2]
Clinical trial update on a combination therapy (Cryoablation + dendritic cell/cytokine-induced killer cells) for advanced liver cancers, spa…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy [Phase 2]
Phase 2 trial evaluating erlotinib plus bevacizumab as second-line therapy for hepatocellular carcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase Ib/II trial evaluating safety and efficacy of QL1706 in patients with advanced hepatocellular carcinoma is ongoing and status is unkno…
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
A clinical trial update for T3011 administered intravenously in patients with advanced solid tumors, including various cancer types, spannin…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial [Phase 3]
Phase 3 clinical trial update for the HeLiX trial evaluating tranexamic acid to reduce hemorrhage during liver resection.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]
Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recu…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 study comparing MLN0128 to sorafenib in advanced or metastatic hepatocellular carcinoma was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer [Phase 2, Phase 3]
Phase 2/3 trial evaluating chemoembolization of the liver with or without sunitinib malate for liver cancer has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial [Phase 2]
Phase II trial evaluating RFA or surgical resection combined with Neo-MASCT for primary hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating irofulven in combination with oxaliplatin in advanced solid tumors has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Personal Resilience Empowerment Program Study [NA]
Clinical trial update for a study titled Personal Resilience Empowerment Program; status completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors [Phase 4]
Clinical trial update for APAP-CYS protein adduct concentrations in patients undergoing liver-directed therapy for hepatic tumors; study wit…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites [NA]
Clinical trial update for Canady Helios cold plasma scalpel at surgical margins and macroscopic tumor sites; status and results data are unc…
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) [Phase 1, Phase 2]
A Phase 1/2 study evaluating electrochemotherapy for treatment of primary liver tumors has completed enrollment with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Programs To Support You During Chemotherapy [NA]
A completed clinical trial sponsored by Wake Forest University Health Sciences focused on providing support during chemotherapy, with result…
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with CAPOX for advanced biliary tract cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer [Phase 2]
Phase 2 trial evaluating CS1008 in combination with sorafenib versus sorafenib alone in advanced liver cancer has completed recruitment with…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy [NA]
Pilot study assessing theragnostically planned liver radiation to optimize radiation therapy for liver cancer, completed with posted results…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer [Phase 2]
Phase 2 trial update for activated CIK cells armed with a bispecific antibody in advanced liver cancer is in early status with limited discl…